文献库搜索 | GeneLibs

Dong(P),Jian(J),Chang(H),Nan(Y),Li(E),Jian... Microsyst Nanoeng 2026-07-21

...MoS₂/SnS₂ vertical heterostructure photodetector was fabricated using an in-situ two-step chemical vapor deposition (CVD...

Keating(C),Suja(LD),Summers(S),Head(IM),Ij... Environ Microbiome 2026-07-21

...MOS) formed in all oil-amended treatments and showed high microbial colonisation, whereas marine dispersant snow showed ...

Hao(Y),Fan(X),Huang(LF),Guo(W),Wang(H),Ren... Small 2026-07-21

...MoS 2 / MoS 2 interfaces and resolve the atomistic evolution of interfacial hydrogen bonds (H-bonds), yielding frictio...

Imam(M),Gupta(N),Narayan(S),Nagpal(K) Pharm Dev Technol 2026-07-29

...MOS electronic tongue confirmed effective masking of the drug's inherent bitterness and the study demonstrated the poten...

Sacchi de Camargo Correia(G),Tawfiq(R),Che... Clin Lung Cancer 2026-06-00

...most commonly thyroiditis (26.7%). The mOS was 81.3 months, numerically longer in those with irAEs versus those without ...

Hidalgo-Robles(Á),Soares-Marangoni(D),Chor... Early Hum Dev 2026-10-00

...most studies small and descriptive. GMA and MOS-R are feasible, reliable tools to assess early motor phenotypes in devel...

Wen(J),Liu(X),Xu(Y),Lin(Z),Hou(M),Gui(Y),C... Cancer Immunol Immunother 2026-01-27

...mOS) and median progression-free survival (mPFS) in the LD group were 31.3 months (95%CI: 16.5-46.2) and 17.0 months (95...

Batist(G),Kavan(P),Augustin(L),Schottel(J)... Cancer Immunol Immunother 2026-01-27

...mOS was 20.3 months. Even though there were no complete responses, the partial response rate and the overall response ra...

Xu(T),Gu(Q),Li(S),Zhang(L),Yuan(Y) NPJ Breast Cancer 2026-02-17

...mOS was 22.2(95% CI: 13.1-31.3) months. The ORR was 33.3%, DCR reached 90.9% and CBR stood at 60.6%. Proteomic analysis ...

Render(AC),Singh(T),Cusumano(JP),Dingwell(JB) bioRxiv 2026-01-21

...MoS L ), and we computed lateral Probability of Instability ( P o I L ) to assess participants' risk of taking unstabl...